Summary: Chronic ethanol consumption has adverse effects on the central nervous system. Hippocampus is one of the target sites of ethanol neurotoxicity. Hippocampal damage is known to result in impairment of learning and memory. This study was aimed to determine whether chronic ethanol consumption could alter the expression levels of brainderived neurotrophic factor (BDNF) and glial-derived neurotrophic factor (GDNF) mRNAs in the hippocampus. Male Wistar rats were given unrestricted access to a liquid diet containing 5% (v/v) ethanol as the sole fluid source for 19 weeks beginning at 10 weeks of age. The expression levels of BDNF and GDNF mRNAs in the hippocampus were analyzed by real-time reverse transcription-polymerase chain reaction (RT-PCR) analysis. The present study revealed that chronic ethanol consumption did not result in significant changes in the expression levels of BDNF and GDNF mRNAs. Our present results showed no significant alteration in the expression of these neurotrophic factors; these results will lead to further studies to examine the possible alterations in the gene expression of various neurotrophins that are related to hippocampal functions including learning and memory.
Chronic ethanol ingestion has adverse effects on the central nervous system (CNS). In fact, numerous studies on laboratory animals and humans have demonstrated that long-term ethanol consumption can result in impairment of cognition, learning, and memory1 -3). It is now well known that even uncomplicated alcoholics without specific neurological or hepatic problems exhibit signs of regional brain damage and cognitive dysfunction. The hippocampus, which is known as one of the target sites for neurotoxic effects, is more sensitive than other brain regions and plays an important role in learning and memory processing.
We have recently reported that in mice that showed intoxication signs following ethanol treatment for several days, the neurons and astrocytes in the hippocampus showed altered immunoreactivities to calbindin-D28k and glial fibrillary acidic protein (GFAP), leading to altered neuron-glial interactions4). This has led to the speculation that the altered immunoreactivities in the hippocampus are associated with various neurological symptoms seen in alcoholic patients, such as cognitive dysfunction and disabilities in orientation or learning. We have now extended this study to evaluate these alterations in the hippocampus with respect to changes in the expression levels of mRNAs of various neurotrophic factors.
Brain-derived neurotrophic factor (BDNF) and glial-derived neurotrophic factor (GDNF) are members of the neurotrophin family of neurotrophic factors that are abundantly and widely dis-tributed in the hippocampus5,6). BDNF is involved in the survival of neurons and maintenance of neuronal functions and participates in neuroprotection against various insults. GDNF is a member of the transforming growth factor superfamily and is distributed throughout multiple brain regions; it also has neuroprotective functions7 -9). Various insults such as alcoholic, epileptic, ischemic, and traumatic insults can induce marked changes in the level of gene expression of neurotrophins, ultimately leading to functional alterations in the CNS10). It is of interest to focus upon BDNF and GDNF separately since they have been known to possess different signal transduction systems7). The purpose of the present study was to ascertain whether chronic ethanol administration may alter the level of gene expression of the two different neurotrophic factors, i.e., BDNF and GDNF.
Materials and Methods
Male Wistar rats obtained from CLEA Japan (Tokyo, Japan) were used in the present study. The rats were divided into two groups, ethanolfed and pair-fed control. The experimental rats (n ¼ 6) were given unrestricted access to a liquid diet (Oriental yeast, Tokyo, Japan) containing 5% (v/v) ethanol (99.5%; Wako, Osaka, Japan) as the sole fluid source for 19 weeks (beginning at 10 weeks of age). The pair-fed control rats (n ¼ 6) were fed an identical liquid diet, except that sucrose was substituted isocalorically for ethanol. This study was conducted in compliance with the guidelines for experimental use and care of laboratory animals established by the Kagawa University Animal Ethics Committee.
At 29 weeks of age, the rats in both groups were anesthetized with sodium pentobarbital (60 mg/kg, i.p.) and perfused intracardially with medical-grade physiological saline (Otsuka, Tokyo, Japan). Using a vibratome, the brains were sectioned in the horizontal plane to yield 1-mm-thick slices. The hippocampal region was removed in chilled physiological saline by using a dissecting microscope. Total RNA was extracted by homogenizing these hippocampal slices in TRIzol reagent (Invitrogen, Carlsbad, USA). The concentration and purity of the extracted RNA were evaluated by optical density measurements at 260 nm and 280 nm using a spectrophotometer. The RNA samples were stored at À80 C until use. Real-time reverse transcription-polymerase chain reaction (Real-time RT-PCR) analysis was performed as described previously11). In brief, reverse transcription was carried out at 37 C for 60 min, followed by 65 C for 10 min using ReadyTo-Go You-Prime First-Strand Beads (Amersham Biosciences, Piscataway, USA). For a 33-mL reaction mixture, the following reagents were used: 1 mL of sample RNA, 29 mL of RNase-free water, Ready-To-Go You-Prime First-Strand Beads, and 3 mL of oligo dT primer (10 mM). Real-time PCR was performed using a LightCycler rapid thermal cycler system (Roche Diagnostics Ltd, Lewes, UK). The reactions were performed in a 20-mL volume with 2 mL of the cDNA diluted ten times, 0.5 mM primers, and reagents included in the LightCyclerFastStart DNA Master SYBR Green I mix (Roche Diagnostics GmbH, Mannheim, Germany). The amplification protocol consisted of one cycle at 95 C for 10 min, followed by 30 cycles at 95 C for 10 s, 65 C for 10 s, 72 C for 20 s, and 87 C for 2 s. Detection of the fluorescent products was carried out at the end of the 87 C extension period. Regarding GDNF, the temperature for annealing was set at 58 C. To assess an appropriate internal control, coamplification of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was performed in each sample. The following forward (F) and reverse (R) primers were used in the present study: BDNF (gene accession number, X67108), F: GAT GAG GAC CAG AAG GTT CG, R: GAT TGG GTA GTT CGG CAT TG; GDNF (NM019139), F: CCC GAA GAT TAT CCT GAC CA, R: TAG CCC AAA CCC AAG TCA GT; GAPDH (AB017801), F: GTA TTG GGC GCC TGG TCA CC, R: CGC TCC TGG AAG ATG GTG ATG G. The above series of realtime PCR procedure was performed three times.
Melting curve analysis and electrophoresis were performed to confirm amplification specificity and exclude genomic contamination, respectively, as described previously11). For the melting curve analysis, the PCR products were melted by gradually increasing the temperature beginning at 65 C in 0.2 C steps. Electrophoresis of the PCR products amplified from cDNA using BDNF, GDNF, and GAPDH primers was carried out on a 2% agarose gel, and the gel was then stained with ethidium bromide. A similar electrophoresis of the amplification products without RT was also performed for each sample as a negative control.
Statistical analysis of the body and brain weights was performed using Mann-Whitney U test or Student's t-test. The quantification data for mRNA was analyzed using the LightCycler analysis software. Data on the mRNA of BDNF and GDNF were expressed as the ratio of the expression levels of BDNF or GDNF mRNA to that of GAPDH mRNA. Statistical analysis with Mann-Whitney U test or Student's t-test was performed by using SigmaStat software (Systat Software, Point Richmond, USA). When the data was not normally distributed and the variances between groups were not homogeneous, the square root transformation of the data was performed prior to statistical analysis.
Results
The mean G SEM values of the body weights of chronic ethanol-fed and pair-fed control rats are shown in Table 1 . At the beginning of ethanol treatment (10 weeks of age), no significant difference in body weight was observed between the two groups; however, at the end of 19 weeks of ethanol treatment, a significant difference was observed. Table 2 shows the mean G SEM values of the brain weights of chronic ethanol-fed and pair-fed control rats at the end of ethanol treatment (29 weeks of age); statistical analysis using Mann-Whitney U test revealed a significant difference between their brain weights. Figure 1 shows a representative electrophoresis Each value is represented as mean G SEM. n: number of animals examined. The body weight data were analyzed using Mann-Whitney U test because the variances were not homogeneous. * p < 0.01 Each value is represented as mean G SEM. n: number of animals examined. * p < 0.01 Fig. 1 . A representative agarose gel electrophoresis of the PCR products amplified from cDNA using BDNF, GDNF, and GAPDH primers; the electrophoresis shows a single band. No band was observed when a similar amplification procedure was performed without RT (data not shown). A similar electrophoresis of the PCR products was carried out for each sample in order to exclude genomic contamination. Molecular weight markers are shown in the left lane.
of the PCR products on 2% agarose gel; a single band confirmed that specific amplification had been accomplished. When RT was excluded, the amplification products were not detected. The above series of procedures was performed for each sample. Additionally, the melting curves of the PCR products amplified using BDNF, GDNF, and GAPDH primer pairs showed a single and sharp transition. This confirms that a single PCR product was present, and primer dimer formation was a rare occurrence within the number of cycles required for quantification. These results provide a strong confirmation that the primers used in this study amplify the target genes BDNF, GDNF, and GAPDH and exclude genomic DNA contamination. Table 3 shows the mean G SEM ratio (Â10 2 ) of the expression levels of BDNF and GDNF mRNAs to that of GAPDH mRNA in chronic ethanol-fed and pair-fed control rats. No significant differences in both BDNF and GDNF mRNA levels were observed between chronic ethanol-fed and pair-fed control rats at the end of ethanol treatment.
Discussion
Chronic ethanol ingestion is known to cause brain damage and cognitive impairment in humans and laboratory animals12 -17). Since various neurotrophic factors are implicated in normal development, functional maintenance, plasticity, and recovery from neuronal damage, these functional disorders in the hippocampus are closely related to alterations in the expression levels of various neurotrophins, including BDNF and GDNF. However, our results demonstrated that chronic ethanol treatment for 19 weeks resulted in no significant alterations in the expression levels of BDNF and GDNF mRNAs in the rat hippocampus.
Despite numerous studies on the effects of chronic ethanol treatment on various neurotrophic factors in the CNS, consistent results have not been obtained. The differences in results across laboratories may arise due to variations in experimental designs such as the length of ethanol treatment, ethanol concentration in the diet, sampling time points, and rat strains. For example, one study showed that the hippocampal BDNF content initially increased after 6-12 weeks of ethanol administration and subsequently decreased after 24 weeks of ethanol administration as a liquid diet containing 8.1%-9.4% (v/v) ethanol18,19). However, in another study, 6.6% (w/v) ethanol administered as a liquid diet for 6 weeks resulted in no alterations in the hippocampal BDNF and Trk B mRNA levels20). Similarly, no change in neurotrophin protein and mRNA levels in the rat hippocampus was observed after ethanol treatment for 28 weeks21). The precise reasons for these discrepancies are unclear but may arise due to significant variations in the ethanol treatment and the sampling times used in the various studies. One of the possible explanations for this discrepancy is the differences in the rat strains. For example, the Long-Evans strain of rats used by the MacLennan' group18) may be more sensitive to ethanol in terms of hippocampal neurotrophin responsiveness than the SpragueDawley rats20).
It has been reported that GDNF protects neurons against ethanol-induced neuronal damage22). We hypothesized that chronic ethanol treatment may increase the expression levels of glial cellassociated proteins, including GDNF, since glial cells are activated by various extrinsic insults. Contrary to our hypothesis, the present study demonstrated that chronic ethanol administration for 19 weeks did not result in a significant change in the expression level of GDNF mRNA when compared with that in controls. Recently, it has been reported that ethanol inhibits GDNF protein release mainly from astrocytes but does not affect the mRNA expression of this protin23). Our present data on GDNF appear to be consistent with this report. Since GDNF is mainly released from astrocytes in the CNS23,24), it is likely that astrocytes are less influenced by chronic ethanol exposure. Further studies are required to understand how GDNF might act against the neurotoxic effects of ethanol.
The alterations in the expression levels of BDNF and GDNF mRNAs after ethanol administration may be explained by several potential mechanisms. One possible explanation is that GDNF and BDNF act in concert through common intracellular targets such as the Ras/Erk pathway and together activate the survival response to the neurotoxic effects of Each value is represented as mean G SEM. n: number of animals examined, BDNF: brain-derived neurotrophic factor, GDNF: glial-derived neurotrophic factor. ethanol25 -29). Our data showing unaltered expression levels of BDNF and GDNF mRNAs appear to be consistent with these reports. However, it is equally likely that BDNF and GDNF act independently30). The precise reason for this discrepancy is unclear at present. Further studies are required to clarify this discrepancy.
Neuropathological changes in human alcoholic patients were reviewed in detail by Harper31). The brain weight of alcoholics is generally lower than that of controls, and the degree of brain atrophy correlates with the rate and amount of alcohol consumption over the lifetime. The reduction in brain weight and volume is strongly correlated with a reduction in white matter volume in the prefrontal cortex32). The mechanism for the ethanolinduced loss of white matter volume remains unknown at present; however, it is strongly speculated that both myelination and axonal integrity are involved in this phenomenon to a certain extent. Demyelination is one of the neuropathological changes observed in human alcoholics31). Myelinassociated proteins such as oligodendrocyte myelin glycoprotein (OMgp), myelin-associated glycoprotein (MAG), and Nogo are categorized as myelin-associated inhibitors and belong to the Nogo receptor (NgR) ligand family. These proteins are expressed by oligodendrocytes and ultimately lead to degeneration following neuronal damage33 -37). We have recently found that ethanol administration to rats for 19 weeks resulted in a significant decrease in the expression levels of OMgp mRNA in the hippocampus (unpublished data). It is speculated that the decreased expression level of OMgp mRNA is attributed to the damage to the oligodendrocytes/myelin sheath induced by chronic ethanol consumption. Our data on OMgp mRNA appear to be consistent with the neuropathological changes in alcoholics, which are characterized by demyelination.
In summary, chronic ethanol administration for 19 weeks did not significantly affect the expression levels of BDNF and GDNF mRNAs in the rat hippocampus. However, the functional implications of alterations in the expression levels of these mRNAs are uncertain at present. It is speculated that various neurological symptoms seen in human alcoholics are closely related to alterations in the expression levels of these important neurotrophic factors. Further experiments that include parameters such as different periods of ethanol administration, multiple sampling points, and various ethanol concentrations in the diet are required to clarify the effects of chronic ethanol administration on alterations in the levels of gene expression of neurotrophins.
